Actinogen Medical

Actinogen Medical Equity

The The Equity of Actinogen Medical (ACW.AX) as of Oct 14, 2026 is 21.37 M AUD. In the previous year, The Equity was 18.34 M AUD — a change of 16.57% (higher).

Equity

21.37 MAUD

YoY

16.57%

Last updated:

In 2026, Actinogen Medical's equity was 21.37 M AUD, a 16.57% increase from the 18.34 M AUD equity in the previous year.

The Actinogen Medical Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
15.66 M AUD
Jan 1, 2020
10.89 M AUD
Jan 1, 2021
17.46 M AUD
Jan 1, 2022
21.74 M AUD
Jan 1, 2023
13.41 M AUD
Jan 1, 2024
19.70 M AUD
Jan 1, 2025
18.34 M AUD
Jan 1, 2026
21.37 M AUD
The Actinogen Medical Equity history
YEAREquityYoY
21.37 MAUD+16.57%
18.34 MAUD-6.91%
19.70 MAUD+46.91%
13.41 MAUD-38.33%
21.74 MAUD+24.53%
17.46 MAUD+60.33%
10.89 MAUD-30.49%
15.66 MAUD-9.23%
17.26 MAUD+84.27%
9.37 MAUD-22.76%
12.13 MAUD-21.04%
15.36 MAUD+1,167.24%
1.21 MAUD—
Access this data via the Eulerpool API
Get Free API Key

Actinogen Medical Stock analysis

What does Actinogen Medical do? Actinogen Medical is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Actinogen Medical's Equity

Actinogen Medical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Actinogen Medical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Actinogen Medical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Actinogen Medical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Actinogen Medical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Actinogen Medical stock

The Equity of Actinogen Medical is 21.37 M AUD in 2026.

The Equity of Actinogen Medical changed from 18.34 M AUD to 21.37 M AUD, representing a 16.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Actinogen Medical since 2006 – with annual values, charts, and detailed analysis.

The Equity's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Actinogen Medical historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Actinogen Medical

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Actinogen Medical